7.00% p.a. Early Redemption Worst of GOAL

Underlying: GlaxoSmithKline / Novartis / Roche SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 52164275 / ISIN: CH0521642758

Last update 29.05.2020
  • Bid

    97.39 %
    Volume: 10'000

  • Ask

    98.39 %
    Volume: 10'000

  • "Worst of" View
Important note: The price data of the underlying asset that are displayed here merely serve as an indication and may not necessarily correspond to the prices that are relevant for the repayment or for any thresholds such as a stop-loss event or a knockout event. Only the sources and reference prices specified in the legally binding product documentation are relevant.

GlaxoSmithKline

NameGlaxoSmithKline
Valor1102657
ISINGB0009252882
ReutersGSK.L
Day high16.91 GBP
Day low16.524 GBP
Previous close16.69945 GBP
52 Week high18.57 GBP
52 Week low13.286 GBP

Roche

NameRoche
Valor1203204
ISINCH0012032048
ReutersROG.S
Day high343.65 CHF
Day low332.70 CHF
Previous close341.25 CHF
52 Week high357.85 CHF
52 Week low260.35 CHF

Novartis

NameNovartis
Valor1200526
ISINCH0012005267
ReutersNOVN.S
Day high84.34 CHF
Day low82.60 CHF
Previous close83.38 CHF
52 Week high96.38 CHF
52 Week low65.09 CHF